Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label pilot study of V3381 (indantadol) in chronic cough
2009-011525-13Phase 2Completed
- Sponsor
- Vernalis
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indantadol in chronic cough and chronic idiopathic cough (CIC), sponsored by Vernalis. Started Jun 2009; status: completed.
02
Drugs
indantadol
03
Conditions
chronic coughchronic idiopathic cough (CIC)
Beyond the preview
Go deeper on 2009-011525-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011525-13.